Endpoints News ٦ مارس ٢٠٢٦ Pfizer gets obesity drug approval in China shortly after buying local rights
Endpoints News ٢٤ فبراير ٢٠٢٦ Pfizer buys China rights to Sciwind’s approved GLP-1 drug in metabolic push
Endpoints News ٧ فبراير ٢٠٢٦ The Hims vs. Novo showdown; Pfizer’s monthly GLP-1 data; Q4 earnings roundup; and more
Endpoints News ٣ فبراير ٢٠٢٦ Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings
Endpoints News ٣ فبراير ٢٠٢٦ Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months
Endpoints News ٨ يناير ٢٠٢٦ French biotech Enodia gets €20.7M aided by Pfizer for protein degrader work
Endpoints News ٥ ديسمبر ٢٠٢٥ OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Endpoints News ٤ ديسمبر ٢٠٢٥ Daiichi Sankyo avoids payout in long-running patent dispute with Pfizer’s Seagen